APA (7th ed.) Citation

Abecassis, A., Roders, N., Fayon, M., Choisy, C., Nelson, E., Harel, S., . . . Bories, J. (2022). CAR‐T cells derived from multiple myeloma patients at diagnosis have improved cytotoxic functions compared to those produced at relapse or following daratumumab treatment. EJHaem, 3(3), 970-974. https://doi.org/10.1002/jha2.479

Chicago Style (17th ed.) Citation

Abecassis, Audrey, et al. "CAR‐T Cells Derived from Multiple Myeloma Patients at Diagnosis Have Improved Cytotoxic Functions Compared to Those Produced at Relapse or Following Daratumumab Treatment." EJHaem 3, no. 3 (2022): 970-974. https://doi.org/10.1002/jha2.479.

MLA (9th ed.) Citation

Abecassis, Audrey, et al. "CAR‐T Cells Derived from Multiple Myeloma Patients at Diagnosis Have Improved Cytotoxic Functions Compared to Those Produced at Relapse or Following Daratumumab Treatment." EJHaem, vol. 3, no. 3, 2022, pp. 970-974, https://doi.org/10.1002/jha2.479.